STAT+: Lawmakers pitch a bill to create $30 billion in ‘biobonds’ to jumpstart drug development

In a bid to jumpstart drug development, a bipartisan group of lawmakers introduced a bill for the U.S. government to back so-called “biobonds,” which would be used to fund small companies and universities that are researching treatments for unmet medical needs.

The LOANS Act, which would authorize a total of $30 billion over an upcoming three-year period, is designed to reduce what the lawmakers called a “perennial shortage of funds” and to help restart research stalled by the Covid-19 pandemic.

Continue to STAT+ to read the full story…

STAT+: Lawmakers pitch a bill to create $30 billion in ‘biobonds’ to jumpstart drug development

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top